Sushmitha Nanja Reddy, MD

Dr. Sushmitha Nanja Reddy is a board-certified hematologist-oncologist who specializes in hematologic (blood) cancers, with a focus on myeloid malignancies and related precursor conditions. Her areas of expertise include:

• Myeloproliferative neoplasms (MPNs): Chronic myeloid leukemia (CML), Polycythemia vera (PV), Essential thrombocythemia (ET), Myelofibrosis (MF), Chronic neutrophilic leukemia (CNL) and Chronic eosinophilic leukemia (CEL)
• Systemic mastocytosis
• Myelodysplastic syndromes (MDS), both low- and high-risk
• MDS/MPN overlap neoplasms: Chronic myelomonocytic leukemia (CMML), Atypical chronic myeloid leukemia (aCML) and MDS/MPN with SF3B1 mutation and thrombocytosis
• Precursor and clonal conditions, including Clonal Hematopoiesis of Indeterminate Potential (CHIP), Clonal Cytopenia of Undetermined Significance (CCUS) and Idiopathic Cytopenia of Undetermined Significance (ICUS)

Research

Dr. Reddy's research focuses on myeloid malignancies, including myeloproliferative neoplasms, low- and high-risk myelodysplastic syndromes and clonal precursor conditions such as CHIP and CCUS.